$48.17
-0.69%
2026-09-04 09:54:58 EDT-$0.33
의료
생명공학
NASDAQ
활발히 거래 중
Rigel Pharmaceuticals, Inc.는 생명공학 회사로서 미국 내 혈액학적 질환 및 암을 가진 환자의 삶을 향상시키는 치료법을 개발하고 제공합니다. 이 회사는 성인 만성 ...
Rigel Pharmaceuticals, Inc.는 생명공학 회사로서 미국 내 혈액학적 질환 및 암을 가진 환자의 삶을 향상시키는 치료법을 개발하고 제공합니다. 이 회사는 성인 만성 ...
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 |
|---|---|---|---|---|---|---|
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 1,286 | $24.20 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 2,000 | $24.20 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 620 | $18.70 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 694 | $12.70 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Employee Stock Option (right to buy) | D | 1,286 | $24.20 |
매수/매도 주식 수와 종가 추세(공통 일간 가격 소스)
X축: 주식 수, 총 주식 수 내림차순
X축: 건수, A+D 건수 내림차순
| 날짜 | 임원 | 직책 | 증권 | 구분 | 주식 수 | 가격 | 금액 |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 1,286 | $24.20 | $31,121.20 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 2,000 | $24.20 | $48,400.00 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 620 | $18.70 | $11,594.00 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | A | 694 | $12.70 | $8,813.80 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Employee Stock Option (right to buy) | D | 1,286 | $24.20 | $31,121.20 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Employee Stock Option (right to buy) | D | 694 | $12.70 | $8,813.80 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Employee Stock Option (right to buy) | D | 620 | $18.70 | $11,594.00 |
| Sep 2, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Employee Stock Option (right to buy) | D | 2,000 | $24.20 | $48,400.00 |
| Sep 1, 2026 | Schorno Dean L | officer: EVP & Chief Financial Officer | Common Stock | D | 928 | $47.50 | $44,080.00 |
| Sep 1, 2026 | Santos David A | officer: EVP, Chief Commercial Officer | Common Stock | D | 874 | $47.50 | $41,515.00 |